In this review we focus on the pathophysiological role of the autonomic nervous system and neurotrophic factors that could be potential targets for novel therapeutic approaches to treat non-alcoholic fatty liver disease. Here, ARTN is linked to metabolic dysfunction-associated steatotic liver disease.